More than 2,000 drugs now in cancer immunotherapy race | | LONDON (Reuters) - The race to develop new immunotherapy treatments against cancer has sparked an unprecedented explosion in the oncology drug pipeline, with more than 2,000 immune system-boosting agents now in development. |
| |
| | |